Soleil Pharmaceuticals Private Limited

Soleil Pharmaceuticals Private Limited - trading in Chennai, Tamil Nadu, India. Directors, charges & compliance details.
CIN U51909TN2022PTC154745 Incorporated 22 August 2022 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company trading MSME · Micro
Data last updated
Revenue · FY 2025
₹32.1 Lakh
▼ 22% YoY
Net loss · FY 2025
₹6.43 Lakh
Net margin -20%
EBITDA · FY 2025
-₹6.43 Lakh
EBITDA margin -20%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹9 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Soleil Pharmaceuticals Private Limited

Data last updated:

Soleil Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 22 August 2022.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2022PTC154745.

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors including Venkata Sudhakara Rao Sankuratripati and Shaheda Shaik.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D No 91 Kamal Ranga Enclave 5th Cross Kumaran Kudil Thoraipakkam, Chennai, Tamil Nadu, India – 600097.

As per the financials filed for FY 2025, the company reported a revenue of ₹32.1 Lakh, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹6.43 Lakh (net margin -20%) and EBITDA of -₹6.43 Lakh (EBITDA margin -20%).

Soleil Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0166030).

Company details

CIN U51909TN2022PTC154745
Registration Number 154745
Incorporation Date 22 August 2022
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0166030
Key People
Venkata Sudhakara Rao Sankuratripati Director Shaheda Shaik Director Maddu Swetha Director

Recognitions & Rankings of Soleil Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-TN-02-0166030

Contact details

Soleil Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu.

  • Registered Address
    D No 91 Kamal Ranga Enclave 5th Cross Kumaran Kudil Thoraipakkam, Chennai, Tamil Nadu, India – 600097
  • Industry
    Trading, Specialty, Wholesale
Comprehensive company report
Soleil Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Soleil Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Soleil Pharmaceuticals Private Limited, buy the company report.

Financials of Soleil Pharmaceuticals Private Limited

FY 2025 filings available

Soleil Pharmaceuticals Private Limited reported revenue of ₹32.1 Lakh (down 22% YoY) for FY 2025.

Revenue · FY 2025
₹32.1 Lakh ▼ 22%
Net loss · FY 2025
₹6.43 Lakh margin -20%
EBITDA · FY 2025
-₹6.43 Lakh margin -20%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 22%
EBITDA CAGR growth
1 year
▲ 46%

Revenue fell 22% in the latest year. EBITDA rose 46% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹6.43 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹6.43 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin-20%
Net Profit Margin-20%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Soleil Pharmaceuticals Private Limited, buy the company report.

Board of directors of Soleil Pharmaceuticals Private Limited

Soleil Pharmaceuticals has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Venkata Sudhakara Rao SankuratripatiDirector22 Aug 20224 Years 2 MonthsCurrent
Shaheda ShaikDirector22 Aug 20224 Years 2 MonthsCurrent
Maddu SwethaDirector22 Aug 20224 Years 2 MonthsCurrent
Raghunath Babu Murukonda
Also directs: Dasari Keshava Healthcare Private Limited, Dasari Keshava Infraquant Private Limited, Dasari Memorial Foundation
Director01 Oct 20224 Years 1 MonthsCurrent
View all directors

Peer comparison

Soleil Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Scynor Pharmaceuticals Private Limited₹32.2 Lakh (FY 2024)122.0%Raisen, Madhya Pradesh, India
Forton Pharmaceuticals Private Limited₹32.12 Lakh (FY 2019)4.0%Pune, Maharashtra, India
Soleil Pharmaceuticals Private Limitedthis company₹32.1 Lakh (FY 2025)-₹6.43 Lakh-20%-22.0%Chennai, Tamil Nadu, India
Moonlight Pharmaceuticals Private Limited₹32.07 Lakh (FY 2017)16.0%Sri Ganganagar, Rajasthan, India
Zonetics Pharmaceuticals Private Limited₹32.03 Lakh (FY 2025)31.0%Gandhinagar, Gujarat, India

To see the full peer comparison of Soleil Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Soleil Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Soleil Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Soleil Pharmaceuticals Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Raghunath Babu Murukonda was appointed as Director on 01 Oct 2022.

AGM
Soleil Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Soleil Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Raghunath Babu Murukonda was appointed as Director.
Appointed
Maddu Swetha was appointed as Director.
Appointed
Shaheda Shaik was appointed as Director.
Appointed
Venkata Sudhakara Rao Sankuratripati was appointed as Director.
Incorporation
22 Aug 2022
Soleil Pharmaceuticals Private Limited was registered on 22 Aug 2022 with Roc Chennai & aged 4 years 2 months as per MCA records.

Frequently asked questions

Soleil Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in specialty, within the trading industry. It was incorporated on 22 August 2022 (4+ years old) and is registered under CIN U51909TN2022PTC154745.

Soleil Pharmaceuticals has 4 current directors:

The latest financial statements of Soleil Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Soleil Pharmaceuticals is U51909TN2022PTC154745. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Soleil Pharmaceuticals was incorporated on 22 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Soleil Pharmaceuticals by revenue are Scynor Pharmaceuticals Private Limited, Forton Pharmaceuticals Private Limited, Moonlight Pharmaceuticals Private Limited, Zonetics Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Raghunath Babu Murukonda was appointed as Director on 01 Oct 2022. Maddu Swetha was appointed as Director on 22 Aug 2022. Shaheda Shaik was appointed as Director on 22 Aug 2022. Soleil Pharmaceuticals has 4 board changes on record in total.

Yes, Soleil Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0166030).

The registered office of Soleil Pharmaceuticals is at D No 91 Kamal Ranga Enclave 5th Cross Kumaran Kudil Thoraipakkam, Chennai, Tamil Nadu, India – 600097.

Soleil Pharmaceuticals operates in the trading industry, in the specialty segment.

Soleil Pharmaceuticals can be reached at its registered office: D No 91 Kamal Ranga Enclave 5th Cross Kumaran Kudil Thoraipakkam, Chennai, Tamil Nadu, India – 600097.